Literature DB >> 27318996

Systemic immunoglobulin light-chain amyloidosis presenting hematochezia as the initial symptom.

Tetsuo Kon1, Naoki Nakagawa2, Fumitsugu Yoshikawa1,3, Kazunao Haba1, Nagako Kitagawa1, Michihiro Izumi1, Setsuo Kumazaki1, Satoshi Ishida1, Ryuichi Aikawa1,3.   

Abstract

Immunoglobulin light-chain (AL) amyloidosis is characterized by the deposition of insoluble fibrils composed of immunoglobulin light chains secreted by monoclonal plasma cells. Given the recent advances in the therapy of AL amyloidosis, it is important to diagnose this disease as early as possible. Herein, we describe the case of a 62-year-old man with hepatitis C virus (HCV)-related cirrhosis presenting with hematochezia. Colonoscopy showed multiple submucosal hematomas within the region ranging from the transverse colon to the sigmoid colon. Kappa immunoglobulin light-chain amyloid deposition was also detected. Bone marrow examination revealed a monoclonal abnormal plasma cell population. Thus, the patient was diagnosed with systemic immunoglobulin light-chain amyloidosis. The hematochezia was conservatively managed. However, because of liver failure caused by liver cirrhosis, the patient developed massive pleural effusion and died of respiratory failure. Postmortem examination revealed amyloid deposition in the esophagus, stomach, duodenum, ileum, descending colon, pancreas, heart, and lung. In these organs, amyloid deposition was limited to the vascular wall. We concluded that AL amyloidosis can present hematochezia arising from submucosal hematoma in the large colon before other systemic symptoms appear.

Entities:  

Keywords:  Gastrointestinal bleeding; Immunoglobulin light-chain amyloidosis; Kappa immunoglobulin light chain; Submucosal hematoma

Mesh:

Substances:

Year:  2016        PMID: 27318996     DOI: 10.1007/s12328-016-0664-5

Source DB:  PubMed          Journal:  Clin J Gastroenterol        ISSN: 1865-7265


  16 in total

Review 1.  What do I need to know about immunoglobulin light chain (AL) amyloidosis?

Authors:  Angela Dispenzieri; Morie A Gertz; Francis Buadi
Journal:  Blood Rev       Date:  2012-04-25       Impact factor: 8.250

Review 2.  The systemic amyloidoses.

Authors:  R H Falk; R L Comenzo; M Skinner
Journal:  N Engl J Med       Date:  1997-09-25       Impact factor: 91.245

3.  Bleeding symptoms and coagulation abnormalities in 337 patients with AL-amyloidosis.

Authors:  A D Mumford; J O'Donnell; J D Gillmore; R A Manning; P N Hawkins; M Laffan
Journal:  Br J Haematol       Date:  2000-08       Impact factor: 6.998

4.  Systemic AL amyloidosis with acquired factor X deficiency: A study of perioperative bleeding risk and treatment outcomes in 60 patients.

Authors:  Carrie A Thompson; Robert Kyle; Morie Gertz; John Heit; Rajiv Pruthi; Animesh Pardanani
Journal:  Am J Hematol       Date:  2010-03       Impact factor: 10.047

Review 5.  Cardiac amyloidosis: pathology, nomenclature, and typing.

Authors:  Joseph J Maleszewski
Journal:  Cardiovasc Pathol       Date:  2015-08-01       Impact factor: 2.185

6.  Clinical recognition of Al type amyloidosis of the luminal gastrointestinal tract.

Authors:  Dustin G James; Gary R Zuckerman; Gregory S Sayuk; Hanlin L Wang; Chandra Prakash
Journal:  Clin Gastroenterol Hepatol       Date:  2007-04-11       Impact factor: 11.382

7.  Cirrhotic cardiomyopathy: Isn't stress evaluation always required for the diagnosis?

Authors:  Mara Barbosa; Joana Guardado; Carla Marinho; Bruno Rosa; Isabel Quelhas; António Lourenço; José Cotter
Journal:  World J Hepatol       Date:  2016-01-28

8.  Light-chain amyloidosis presenting with rapidly progressive submucosal hemorrhage of the stomach.

Authors:  Song-Yi Kim; Suk-Bae Moon; Seung Koo Lee; Seong Kweon Hong; Yang Hee Kim; Gi Bong Chae; Sung-Bae Park
Journal:  Asian J Surg       Date:  2013-11-15       Impact factor: 2.767

Review 9.  Light chain (AL) amyloidosis: update on diagnosis and management.

Authors:  Michael Rosenzweig; Heather Landau
Journal:  J Hematol Oncol       Date:  2011-11-18       Impact factor: 17.388

10.  The clinical features and outcomes of systemic AL amyloidosis: a cohort of 231 Chinese patients.

Authors:  Xianghua Huang; Qingwen Wang; Song Jiang; Wencui Chen; Caihong Zeng; Zhihong Liu
Journal:  Clin Kidney J       Date:  2014-11-13
View more
  2 in total

1.  Surgically treated rare intestinal bleeding due to submucosal hematoma in a patient on oral anticoagulant therapy: A case report.

Authors:  Wei-Hua Yu; Chao Feng; Tie-Mei Han; Shun-Xian Ji; Lan Zhang; Yi-Yang Dai
Journal:  Medicine (Baltimore)       Date:  2018-11       Impact factor: 1.817

2.  Intramural hematoma of colon: Case report of 2 cases.

Authors:  Jing Wang; Xiaoyan Sun; Hongkun Shi; Dianbo Cao
Journal:  Medicine (Baltimore)       Date:  2020-03       Impact factor: 1.889

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.